Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2015

Aug 20, 2015

29777_dirs_2015-08-20_2a1898a6-1109-4545-b5a4-03a4cf36722f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-06-01

Reporting Person: Ford Robert B (Executive Vice President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-06-01 Option (right to buy) $48.90 A 14243 Acquired 2025-05-31 Common shares (14243) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,748 on 6/1/2016, 4,747 on 6/1/2017, and 4,748 on 6/1/2018.

F2: This Form 4/A amends the number of derivative securities acquired on June 1, 2015.